This is a task order development of pbpk model

Ended Awarded Last action

Contract number
75F40123F19018
Awardee
Awarding agency
Obligated
$253,100

Award facts

Contract value 100% obligated
$253,099.53 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Available for Competition Only One Source
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00002 -$385
Other Administrative Action P00001 $0
Original award $253,485

About this award

The Food and Drug Administration issued a delivery order to Goldbelt C6, LLC, an Alaska Native Corporation and certified 8(a) small disadvantaged business, on September 18, 2023, with a ceiling value of $253,099.53 under the FDA's $20 million single-award indefinite delivery contract for research and development support services.

The delivery order calls for development of a PBPK (physiologically-based pharmacokinetic) model. Place of performance is Silver Spring, MD. The order is priced on a firm fixed price basis with an ultimate completion date of September 17, 2024.

Quick answers

Who was awarded contract 75F40123F19018?

75F40123F19018 was awarded to Goldbelt C6, LLC by Food and Drug Administration (Department of Health and Human Services) on September 18, 2023.

How much is contract 75F40123F19018 worth?

The government has obligated $253,100 on 75F40123F19018.

Is contract 75F40123F19018 an order under another contract?

Yes. 75F40123F19018 is a delivery order under 75F40123D00017, an indefinite delivery contract.

Was contract 75F40123F19018 competed?

The extent of competition for 75F40123F19018 was not available for competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award